Focus: EXACT Therapeutics is a newly founded (2024) Norwegian biotech specializing in ultrasound-enhanced drug delivery and diagnostic technologies across oncology, immunology, gastroenterology, and infectious diseases. The company is publicly listed but remains in early-stage development with minimal marketed products.
Profile data last refreshed 18h ago · AI intelligence enriched 1w ago
No open roles listed right now. Follow EXACT Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for EXACT Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from EXACT Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
No open positions listed yet. Check their careers page directly.
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Acoustic cluster therapy mediated enhancement of [(68)Ga]Ga-PSMA-617 in a murine glioblastoma multiforme model verified by simultaneous PET/MRI.
A Comparative Analysis of Orthotopic and Subcutaneous Pancreatic Tumour Models: Tumour Microenvironment and Drug Delivery.
Showing 5 of 8 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo